AGEN
Price
$3.05
Change
-$0.09 (-2.87%)
Updated
Apr 29 closing price
Capitalization
77.19M
CDTX
Price
$21.09
Change
+$0.06 (+0.29%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
263.86M
Ad is loading...

AGEN vs CDTX

Header iconAGEN vs CDTX Comparison
Open Charts AGEN vs CDTXBanner chart's image
Agenus
Price$3.05
Change-$0.09 (-2.87%)
Volume$667.1K
Capitalization77.19M
Cidara Therapeutics
Price$21.09
Change+$0.06 (+0.29%)
Volume$3.26K
Capitalization263.86M
AGEN vs CDTX Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. CDTX commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and CDTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (AGEN: $3.14 vs. CDTX: $21.03)
Brand notoriety: AGEN and CDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 221% vs. CDTX: 99%
Market capitalization -- AGEN: $77.19M vs. CDTX: $264.99M
AGEN [@Biotechnology] is valued at $77.19M. CDTX’s [@Biotechnology] market capitalization is $264.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileCDTX’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • CDTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 5 TA indicator(s) are bullish while CDTX’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 5 bullish, 5 bearish.
  • CDTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than CDTX.

Price Growth

AGEN (@Biotechnology) experienced а +35.93% price change this week, while CDTX (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

CDTX is expected to report earnings on Aug 13, 2024.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($264M) has a higher market cap than AGEN($77.2M). AGEN YTD gains are higher at: 14.599 vs. CDTX (-21.763). AGEN has higher annual earnings (EBITDA): -101.3M vs. CDTX (-175.87M). CDTX has more cash in the bank: 190M vs. AGEN (40.4M). CDTX has less debt than AGEN: CDTX (3.58M) vs AGEN (94.9M). AGEN has higher revenues than CDTX: AGEN (103M) vs CDTX (1.28M).
AGENCDTXAGEN / CDTX
Capitalization77.2M264M29%
EBITDA-101.3M-175.87M58%
Gain YTD14.599-21.763-67%
P/E Ratio0.45N/A-
Revenue103M1.28M8,078%
Total Cash40.4M190M21%
Total Debt94.9M3.58M2,654%
FUNDAMENTALS RATINGS
AGEN vs CDTX: Fundamental Ratings
AGEN
CDTX
OUTLOOK RATING
1..100
2826
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (50) in the Biotechnology industry is somewhat better than the same rating for AGEN (97). This means that CDTX’s stock grew somewhat faster than AGEN’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that CDTX’s stock grew similarly to AGEN’s over the last 12 months.

CDTX's SMR Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that CDTX’s stock grew similarly to AGEN’s over the last 12 months.

CDTX's Price Growth Rating (38) in the Biotechnology industry is in the same range as AGEN (46). This means that CDTX’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's P/E Growth Rating (94) in the Biotechnology industry is in the same range as CDTX (100). This means that AGEN’s stock grew similarly to CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENCDTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
+16.30%
NCNA - AGEN
92%
Closely correlated
+1.82%
CDTX - AGEN
91%
Closely correlated
-2.37%
WINT - AGEN
91%
Closely correlated
-5.79%
NBY - AGEN
90%
Closely correlated
+0.86%
SNPX - AGEN
90%
Closely correlated
+4.94%
More

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.37%
WINT - CDTX
94%
Closely correlated
-5.79%
NBY - CDTX
93%
Closely correlated
+0.86%
NCNA - CDTX
93%
Closely correlated
+1.82%
SNPX - CDTX
93%
Closely correlated
+4.94%
BPTSY - CDTX
92%
Closely correlated
N/A
More